Patents by Inventor Michael T. Falduto

Michael T. Falduto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6399371
    Abstract: The present invention provides novel complementary DNA (cDNA) sequences encoding human matrix metalloprotease proteins (MMP-ABT). The present invention also provides recombinant DNA molecules encoding human matrix metalloprotease polypeptides and processes for producing the novel proteins. The cDNA is cloned into expression vectors for expression in recombinant hosts. The cDNA is useful to produce recombinant full length MMP-ABTs or fragments thereof. The cDNA and the recombinant proteins derived therefrom and/or antibodies to the proteins are useful in diagnostic assays and for the development of therapeutic agents that affect MMP function.
    Type: Grant
    Filed: September 7, 1999
    Date of Patent: June 4, 2002
    Assignee: Abbott Laboratories
    Inventors: Michael T. Falduto, Scott R. Magnuson, Douglas W. Morgan
  • Publication number: 20020031817
    Abstract: The present invention provides novel complementary DNA (cDNA) sequences encoding human matrix metalloprotease proteins (MMP-ABT). The present invention also provides recombinant DNA molecules encoding human matrix metalloprotease polypeptides and processes for producing the novel proteins. The cDNA is cloned into expression vectors for expression in recombinant hosts. The cDNA is useful to produce recombinant full length MMP-ABTs or fragments thereof. The cDNA and the recombinant proteins derived therefrom and/or antibodies to the proteins are useful in diagnostic assays and for the development of therapeutic agents that affect MMP function.
    Type: Application
    Filed: September 7, 1999
    Publication date: March 14, 2002
    Inventors: MICHAEL T. FALDUTO, SCOTT R. MAGNUSON, DOUGLAS W. MORGAN